ClinVar Genomic variation as it relates to human health
NM_000179.3(MSH6):c.4010G>C (p.Cys1337Ser)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000179.3(MSH6):c.4010G>C (p.Cys1337Ser)
Variation ID: 2676803 Accession: VCV002676803.3
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2p16.3 2: 47806787 (GRCh38) [ NCBI UCSC ] 2: 48033926 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 30, 2023 May 1, 2024 Aug 3, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000179.3:c.4010G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000170.1:p.Cys1337Ser missense NM_001281492.2:c.3620G>C NP_001268421.1:p.Cys1207Ser missense NM_001281493.2:c.3104G>C NP_001268422.1:p.Cys1035Ser missense NM_001281494.2:c.3104G>C NP_001268423.1:p.Cys1035Ser missense NM_001406795.1:c.4106G>C NP_001393724.1:p.Cys1369Ser missense NM_001406796.1:c.4010G>C NP_001393725.1:p.Cys1337Ser missense NM_001406797.1:c.3713G>C NP_001393726.1:p.Cys1238Ser missense NM_001406798.1:c.3836G>C NP_001393727.1:p.Cys1279Ser missense NM_001406799.1:c.3485G>C NP_001393728.1:p.Cys1162Ser missense NM_001406800.1:c.*31G>C 3 prime UTR NM_001406801.1:c.3708G>C NP_001393730.1:p.Leu1236Phe missense NM_001406802.1:c.3906G>C NP_001393731.1:p.Leu1302Phe missense NM_001406803.1:c.3146G>C NP_001393732.1:p.Cys1049Ser missense NM_001406804.1:c.3932G>C NP_001393733.1:p.Cys1311Ser missense NM_001406805.1:c.3713G>C NP_001393734.1:p.Cys1238Ser missense NM_001406806.1:c.3485G>C NP_001393735.1:p.Cys1162Ser missense NM_001406807.1:c.3485G>C NP_001393736.1:p.Cys1162Ser missense NM_001406808.1:c.4005G>C NP_001393737.1:p.Leu1335Phe missense NM_001406809.1:c.4010G>C NP_001393738.1:p.Cys1337Ser missense NM_001406811.1:c.3104G>C NP_001393740.1:p.Cys1035Ser missense NM_001406812.1:c.3104G>C NP_001393741.1:p.Cys1035Ser missense NM_001406813.1:c.4016G>C NP_001393742.1:p.Cys1339Ser missense NM_001406814.1:c.3104G>C NP_001393743.1:p.Cys1035Ser missense NM_001406815.1:c.3104G>C NP_001393744.1:p.Cys1035Ser missense NM_001406816.1:c.3104G>C NP_001393745.1:p.Cys1035Ser missense NM_001406817.1:c.2444G>C NP_001393746.1:p.Cys815Ser missense NM_001406818.1:c.3713G>C NP_001393747.1:p.Cys1238Ser missense NM_001406819.1:c.3713G>C NP_001393748.1:p.Cys1238Ser missense NM_001406820.1:c.3713G>C NP_001393749.1:p.Cys1238Ser missense NM_001406821.1:c.3713G>C NP_001393750.1:p.Cys1238Ser missense NM_001406822.1:c.3708G>C NP_001393751.1:p.Leu1236Phe missense NM_001406823.1:c.3104G>C NP_001393752.1:p.Cys1035Ser missense NM_001406824.1:c.3713G>C NP_001393753.1:p.Cys1238Ser missense NM_001406825.1:c.3713G>C NP_001393754.1:p.Cys1238Ser missense NM_001406826.1:c.3842G>C NP_001393755.1:p.Cys1281Ser missense NM_001406827.1:c.3713G>C NP_001393756.1:p.Cys1238Ser missense NM_001406828.1:c.3713G>C NP_001393757.1:p.Cys1238Ser missense NM_001406829.1:c.3104G>C NP_001393758.1:p.Cys1035Ser missense NM_001406830.1:c.3713G>C NP_001393759.1:p.Cys1238Ser missense NM_001406831.1:c.791G>C NP_001393760.1:p.Cys264Ser missense NM_001406832.1:c.857G>C NP_001393761.1:p.Cys286Ser missense NM_001407362.1:c.1955G>C NP_001394291.1:p.Cys652Ser missense NR_176256.1:n.2940G>C non-coding transcript variant NR_176257.1:n.4271G>C non-coding transcript variant NR_176258.1:n.4200G>C non-coding transcript variant NR_176259.1:n.4099G>C non-coding transcript variant NR_176260.1:n.2044G>C NR_176261.1:n.3981G>C non-coding transcript variant NC_000002.12:g.47806787G>C NC_000002.11:g.48033926G>C NG_007111.1:g.28641G>C NG_008397.1:g.103889C>G LRG_219:g.28641G>C LRG_219t1:c.4010G>C LRG_219p1:p.Cys1337Ser - Protein change
- C1035S, C1049S, C1162S, C1207S, C1238S, C1279S, C1281S, C1311S, C1337S, C1339S, C1369S, C264S, C286S, C652S, C815S, L1236F, L1302F, L1335F
- Other names
- -
- Canonical SPDI
- NC_000002.12:47806786:G:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MSH6 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
9161 | 9479 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Aug 3, 2023 | RCV003461940.1 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Feb 18, 2023 | RCV003759872.2 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Sep 26, 2022 | RCV004364785.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Aug 03, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Endometrial carcinoma
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004195622.1
First in ClinVar: Dec 30, 2023 Last updated: Dec 30, 2023 |
|
|
Uncertain significance
(Feb 18, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary nonpolyposis colorectal neoplasms
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV004431513.1
First in ClinVar: Feb 20, 2024 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces cysteine, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 1337 of the MSH6 protein … (more)
This sequence change replaces cysteine, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 1337 of the MSH6 protein (p.Cys1337Ser). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MSH6-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MSH6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Uncertain significance
(Sep 26, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV005003932.1
First in ClinVar: May 01, 2024 Last updated: May 01, 2024 |
Comment:
The c.4010G>C (p.C1337S) alteration is located in exon 10 (coding exon 10) of the MSH6 gene. This alteration results from a G to C substitution … (more)
The c.4010G>C (p.C1337S) alteration is located in exon 10 (coding exon 10) of the MSH6 gene. This alteration results from a G to C substitution at nucleotide position 4010, causing the cysteine (C) at amino acid position 1337 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Sep 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.